Port Jefferson, NY, United States of America

Kongzhen Hu

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: The State University of New York. Active years: 2021-2023.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Kongzhen Hu

Introduction

Kongzhen Hu is a notable inventor based in Port Jefferson, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit the activity of Fatty Acid Binding Proteins (FABPs). With a total of 2 patents to his name, his work is recognized for its potential impact on medical treatments.

Latest Patents

Kongzhen Hu's latest patents include the invention of Alpha-truxillic acid derivatives and pharmaceutical compositions thereof. This invention provides a compound and a method for inhibiting the activity of a Fatty Acid Binding Protein (FABP) by contacting the FABP with a compound that has a specific structure, referred to as Formula (I). This innovative approach could lead to advancements in therapeutic applications.

Career Highlights

Kongzhen Hu is affiliated with the State University of New York, where he continues to engage in research and development. His academic background and ongoing projects contribute to the advancement of pharmaceutical sciences.

Collaborations

Some of his notable coworkers include Iwao Ojima and Dale Deutsch. Their collaborative efforts enhance the research environment and foster innovation in their respective fields.

Conclusion

Kongzhen Hu's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for new therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…